海辰药业：甲硫酸新斯的明注射液获得药品注册证书

Core Viewpoint - Hainan Pharmaceutical has received approval from the National Medical Products Administration for the registration of Methanesulfonate Injection of Neostigmine, which is an anticholinesterase drug used for various medical conditions [1] Group 1 - The newly approved drug is indicated for the reversal of residual neuromuscular blockade after surgery, treatment of myasthenia gravis, and management of postoperative functional bowel distension and urinary retention [1]